Skip to main content
OpenTrials
Completed

NCT Number: NCT05135143

Role of Antioxidants in the Reduction of Oxidative Stress in Infertile Patients

Numerous studies verify that the majority of cases of male infertility belong to the group diagnosed with oligoasthenoteratozoospermia (OAT), which means a decrease in the number of sperm in the ejaculate to 15 million / ml, reduced sperm motility of the spermatozoa and morphological disorders of the neck or tail of the sperm.

Genuine scientific studies can not pinpoint the cause of these changes, however, recent advances in science shed light on this issue by confirming the reason, which is as a result of the action of free radicals - oxidative stress.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 4

Primary location

Univeristy of Tetova

Tetovo, 6338, North Macedonia

About this study

The enlightenment project in the field of male infertility in North Macedonia will include a wide team of: students, general practitioners, assistants, professors of pre-clinical subjects, professors and specialists in the field of gynecology, urology and andrologists. The involvement of such a large number of professionals once again verifies the seriousness and determination that this scientific project has.

Investigators hope to contribute generously to:

  • Identifying new cases and taking measures early, in order to overcome fertilization problems;
  • For the first time in North Macedonia there will be a more accurate picture of the prevalence of male infertility;
  • Expanding current scientific knowledge about the role of oxidative stress, its laboratory evaluation, and the impact of antioxidant supplements;
  • Standardization of doses and type of antioxidant supplements that will be used during the realization of this dissertation and evaluation of their clinical effect in men with OAT;
  • After the implementation of antioxidant therapy, investigators expect that the results of live births and spontaneous pregnancies will increase, while the number of miscarriages will decrease;
  • Acquisition of knowledge on laboratory and clinical evaluation techniques of infertile men, which would later lead to the establishment of an andrological laboratory. Investigators anticipate this laboratory to function within the Faculty of Medical Sciences, where all procedures will be performed, from diagnosis to the operation of assisted reproduction techniques (TRA). This, in addition to the material benefit for the benefit of the University of Tetova, also has a benefit in terms of staff, which will be professionalized and trained during the realization of this dissertation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age, 19-45 years;
  • infertility, 2 years;
  • regular sexual intercourse with a fertile female.
  • The female partner was defined as being fertile if she had undergone a negative infertility workup (biphasic basal body temperature, P evaluation in luteal phase, ultrasound ovary and uterus evaluation, and hysterosalpingogram to study tubal patency)

Exclusion criteria

  • use of antioxidant agents or vitamins within 8 weeks prior to inclusion in the study,
  • a history of excessive consumption of alcohol 40 days prior to the start of the trial,
  • patients that showed lower than 5% motility and less than 1 × 106/ml sperm concentration, - patients with any acute or chronic disease or
  • who are undergoing some kind of treatment with any class of drugs and
  • subjects with known hypersensitivity to ingredients in the antioxidant formula.

Treatment and study plan

Antioxidant formula

Combination Product

Administration of antioxidant formula 3 times a day and once daily.

Primary outcomes

  1. Sperm parameters

    Time frame: 6 months

    Concentration (10x6 ml)

  2. Sperm parameters

    Time frame: 6 months

    Morphology (percentage)

  3. Sperm parameters

    Time frame: 6 months

    Motility (percentage)

Secondary outcomes

  1. oxidative stress parameters

    Time frame: 6 months

    MDA (mg/ml)

  2. oxidative stress parameters

    Time frame: 6 months

    Caspase 3 (IU/ml)

  3. oxidative stress parameters

    Time frame: 6 months

    TAC (IU/ml)

Sponsors and collaborators

Lead sponsor

University of Tetova

Other

Collaborators

  • University of Tetova, Faculty of Medical Sciences

Registry information

Acronym: OAT

Important dates

Study start
2017
Primary completion
2019
Study completion
2021
First posted
Nov 26, 2021
Registry last updated
Nov 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.